Alexion to start Soliris in COVID-19 Phase II trial in next few days
Alexion to start Soliris in COVID-19 Phase II trial in next few days: Alexion Pharmaceuticals is revving up to enter the COVID-19 drug development race with Soliris (eculizumab), a drug that is already approved for other indications, a source familiar with the trial told Reynald Castañeda
VARINDIA- INDIA'S FRONTLINE IT MAGAZINE
VARINDIA- INDIA'S FRONTLINE IT MAGAZINE
Comments
Post a Comment